Needham & Company
-
Celator® Pharmaceuticals to Present at 15th Annual Needham Healthcare Conference
-
Celator® Pharmaceuticals Closes $43.7 Million Underwritten Financing
-
Celator Pharmaceuticals (CPXX) Prices 4M Common Stock Offering at $9.50/Share
-
Celator® Pharmaceuticals Announces Pricing Of A $38.0 Million Public Offering Of Common Stock
-
Celator Pharmaceuticals (CPXX) Plans Common Stock Offering
-
Celator® Pharmaceuticals Announces Proposed Public Offering Of Common Stock
-
Celator® Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference

